BlueCrest Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,100
Closed -$296K 195
2023
Q1
$296K Buy
+4,100
New +$320K 0.01% 220
2018
Q1
Sell
-68,230
Closed -$2.23M 1454
2017
Q4
$2.23M Buy
+68,230
New +$2.36M 0.06% 254
2017
Q2
Sell
-9,845
Closed -$429K 886
2017
Q1
$429K Buy
+9,845
New +$399K 0.02% 461
2016
Q2
Sell
-10,943
Closed -$603K 839
2016
Q1
$603K Buy
+10,943
New +$625K 0.04% 470
2015
Q4
Sell
-9,698
Closed -$643K 955
2015
Q3
$643K Sell
9,698
-19,189
-66% -$1.48M 0.02% 540
2015
Q2
$2.26M Buy
+28,887
New +$2.08M 0.07% 316
2015
Q1
Sell
-8,900
Closed -$545K 595
2014
Q4
$545K Buy
+8,900
New +$518K 0.02% 441

Other funds holding ACHC

BlueCrest Capital Management's ACHC Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Acadia Healthcare (ACHC) in Q2 2023, closing a stake of 4,100 shares — an estimated $296K sold.

BlueCrest Capital Management first reported a position in ACHC in Q4 2014 and held it in 7 quarters. The position peaked at $2.26M in Q2 2015. 280 funds tracked by Wall St. Rank hold ACHC as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Acadia Healthcare position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 4,100 Acadia Healthcare shares in Q2 2023, an estimated $296K.
  • BlueCrest Capital Management first reported a position in Acadia Healthcare in Q4 2014 and held it in 7 quarters.
  • BlueCrest Capital Management's Acadia Healthcare position peaked at $2.26M in Q2 2015.
  • 280 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.